Literature DB >> 27813875

The Type I Interferonopathies.

Min Ae Lee-Kirsch1.   

Abstract

Type I interferons (IFNs) play a central role in the immune defense against viral infections. Type I IFN activation is induced by pattern-recognition receptors of the innate immune system that sense pathogen-derived nucleic acids. Cellular responses to type I IFN signaling are orchestrated by a complex network of regulatory pathways that involve both the innate and adaptive immune system. The genetic and molecular dissection of rare Mendelian disorders associated with constitutive overproduction of type I IFN has provided unique insight into cell-intrinsic disease mechanisms that initiate and sustain autoinflammation and autoimmunity and that are caused by disturbances in the intracellular nucleic acid metabolism or in cytosolic nucleic acid-sensing pathways. Collectively, these findings have greatly advanced our understanding of mechanisms that protect the organism against inappropriate immune activation triggered by self nucleic acids while maintaining a prompt and efficient immune response to foreign nucleic acids derived from invading pathogens.

Entities:  

Keywords:  autoimmunity; autoinflammation; innate immunity; nucleic acid metabolism; nucleic acid sensing; type I interferon

Mesh:

Substances:

Year:  2016        PMID: 27813875     DOI: 10.1146/annurev-med-050715-104506

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  65 in total

Review 1.  Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors.

Authors:  Charlotte Lässig; Karl-Peter Hopfner
Journal:  J Biol Chem       Date:  2017-04-14       Impact factor: 5.157

Review 2.  Too much of a good thing: Detrimental effects of interferon.

Authors:  Nancy C Reich
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

3.  An alternative model for type I interferon induction downstream of human TLR2.

Authors:  Timo Oosenbrug; Michel J van de Graaff; Mariëlle C Haks; Sander van Kasteren; Maaike E Ressing
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

4.  LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity.

Authors:  Wei Liu; Ziqiao Wang; Lun Liu; Zongheng Yang; Shuo Liu; Zhongfei Ma; Yin Liu; Yuanwu Ma; Lianfeng Zhang; Xuan Zhang; Minghong Jiang; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

5.  Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.

Authors:  Caitlin M Miller; Bradley S Barrett; Jianfang Chen; James H Morrison; Caleb Radomile; Mario L Santiago; Eric M Poeschla
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 6.  [Genetic methods for analysis of autoinflammatory diseases].

Authors:  M Bienias; N König; C Wolf; S Kretschmer; A Rösen-Wolff; R Berner; V Tüngler; M A Lee-Kirsch
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

Review 7.  Animal Models for the Study of Nucleic Acid Immunity: Novel Tools and New Perspectives.

Authors:  Isabelle K Vila; Maxence Fretaud; Dimitrios Vlachakis; Nadine Laguette; Christelle Langevin
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

8.  SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression in vivo.

Authors:  Tanja Blumer; Mairene Coto-Llerena; Francois H T Duong; Markus H Heim
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

Review 9.  Type I interferon in the pathogenesis of systemic lupus erythematosus.

Authors:  Mariana Postal; Jessica F Vivaldo; Ruth Fernandez-Ruiz; Jacqueline L Paredes; Simone Appenzeller; Timothy B Niewold
Journal:  Curr Opin Immunol       Date:  2020-11-24       Impact factor: 7.486

Review 10.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.